Sweden In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

The Sweden In-Vitro Diagnostics Market is segmented by Test ( Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, Other Types), Product, Usability, Application, and End Users.

Sweden In-Vitro Diagnostics Market Size

Netherlands In vitro Diagnostics Market-4
share button
Study Period 2018 - 2028
Base Year For Estimation 2022
Forecast Data Period 2023 - 2028
Historical Data Period 2018 - 2021
CAGR 5.20 %
Market Concentration Medium

Major Players


*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Sweden In-Vitro Diagnostics Market Analysis

The Swedish in vitro diagnostics market is expected to witness a CAGR of 5.2% during the forecast period.

  • Certain factors that are driving the market growth include high prevalence of chronic diseases, increasing use of point-of-care (POC) diagnostics, advanced technologies, and increasing awareness and acceptance of personalized medicine and companion diagnostics.
  • Rising geriatric population is expected to be one of the major factor impacting growth of the market. According to Statistics Sweden's population projection, in 2018, the share of people aged 80 and older will increase most to 19.86% of total population, and in 2028, their share is expected to be 255,000 more people than today, an increase of 50 percent.
  • Effective management of patients with one or more chronic disease is a commonly debated concern in Sweden. More effective primary care delivery may increase the overall efficiency and responsiveness of the health system. Hence, the increasing health expenditure in the country is expected to fuel the market growth over the forecast period.

Sweden In-Vitro Diagnostics Market Trends

This section covers the major market trends shaping the Sweden In-Vitro Diagnostics Market according to our research experts:

The Reagent Segment is Expected to Hold the Highest Market Share During the Forecast Period

The reagent segment of the market studied includes chemical, biological, or immunological components, solutions, or preparations intended by the manufacturer to be used during the in vitro diagnosis process. Given the high cost of many diagnostic platforms, it is common for manufacturers to lease equipment instead of selling technology outright to end users. In these arrangements, the lease is tied to contracts to purchase associated reagents or assays for the equipment over the term of the contract. Many diagnostic companies have in excess of 75% of sales from consumables, such as assays and reagents, and such agreements guarantee the generation of cyclic revenues associated with the sale of reagents and other consumables.


Sweden In-Vitro Diagnostics Industry Overview

The Swedish in vitro diagnostics market is highly competitive and consists of a number of major players. Companies, like Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories Inc., Danaher Corporation, Johnson & Johnson, Roche Diagnostics, Siemens Healthcare, and Thermo Fisher Scientific Inc., among others, hold the substantial market share in the Swedish in vitro diagnostics market.

Sweden In-Vitro Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Becton, Dickinson, and Company

  3. Bio-Rad Laboratories, Inc.

  4. Danaher Corporation

  5. Thermo Fisher Scientific Inc.

*Disclaimer: Major Players sorted in no particular order

Netherlands In vitro Diagnostics Market-2

Sweden In-Vitro Diagnostics Market Report - Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

      3. 4.2.3 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

      2. 4.3.2 Cumbersome Reimbursement Procedures

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Molecular Diagnostics

      3. 5.1.3 Immuno Diagnostics

      4. 5.1.4 Haematology

      5. 5.1.5 Other Types

    2. 5.2 Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 Usability

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Other Applications

    5. 5.5 End Users

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals & Clinics

      3. 5.5.3 Other End Users


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson, and Company

      3. 6.1.3 BioMerieux

      4. 6.1.4 Bio-Rad Laboratories Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 QIAGEN

      7. 6.1.7 F. Hoffmann-La Roche AG

      8. 6.1.8 Siemens Healthcare

      9. 6.1.9 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments

Sweden In-Vitro Diagnostics Industry Segmentation

As per the scope of this report, in vitro diagnostics involves medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases.

By Test Type
Clinical Chemistry
Molecular Diagnostics
Immuno Diagnostics
Other Types
Other Products
Disposable IVD Devices
Reusable IVD Devices
Infectious Disease
Autoimmune Disease
Other Applications
End Users
Diagnostic Laboratories
Hospitals & Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Sweden In-Vitro Diagnostics Market Research FAQs

The Sweden In-Vitro Diagnostics Market is projected to register a CAGR of 5.2% during the forecast period (2023-2028).

Abbott Laboratories, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Danaher Corporation and Thermo Fisher Scientific Inc. are the major companies operating in the Sweden In-Vitro Diagnostics Market.

Sweden In-Vitro Diagnostics Industry Report

Statistics for the 2023 Sweden In-Vitro Diagnostics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Sweden In-Vitro Diagnostics analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!